Avacta gets MHRA green-light to start phase I trial for ‘pro-drug’ chemotherapy February 19, 2021 Auto Bot News 0 AVA6000 is pro-drug form of the chemotherapy doxorubicin, modified using Avacta’s pre|CISION chemistry